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Can a Novel Clinical Risk Score Improve Pneumonia Prediction in
Acute Stroke Care? A UK Multicenter Cohort Study
Craig J. Smith, MD, MRCP; Benjamin D. Bray, MRCP; Alex Hoffman, MSc; Andreas Meisel, MD; Peter U. Heuschmann, MD, MPH; Charles D. A.
Wolfe, FFPHM; Pippa J. Tyrrell, MD, FRCP; Anthony G. Rudd, FRCP; on behalf of the Intercollegiate Stroke Working Party Group
Background-—Pneumonia frequently complicates stroke andhasamajor impact onoutcome.Wederived and internally validated a simple
clinical risk score for predicting stroke-associated pneumonia (SAP), and compared the performance with an existing score (A2DS2).
Methods and Results-—We extracted data for patients with ischemic stroke or intracerebral hemorrhage from the Sentinel Stroke
National Audit Programme multicenter UK registry. The data were randomly allocated into derivation (n=11 551) and validation
(n=11 648) samples. A multivariable logistic regression model was ﬁtted to the derivation data to predict SAP in the ﬁrst 7 days of
admission. The characteristics of the score were evaluated using receiver operating characteristics (discrimination) and by plotting
predicted versus observedSAP frequency in deciles of risk (calibration). PrevalenceofSAPwas6.7%overall. Theﬁnal 22-point score (ISAN:
prestroke Independence [modiﬁed Rankin scale], Sex,Age,National Institutes of Health Stroke Scale) exhibited good discrimination in the
ischemic stroke derivation (C-statistic 0.79; 95%CI 0.77 to 0.81) and validation (C-statistic 0.78; 95%CI 0.76 to 0.80) samples. It waswell
calibrated in ischemic stroke andwas further classiﬁed intomeaningful riskgroups (low0 to5,medium6 to10, high11 to14, andvery high
≥15) associated with SAP frequencies of 1.6%, 4.9%, 12.6%, and 26.4%, respectively, in the validation sample. Discrimination for both
scores was similar, although they performed less well in the intracerebral hemorrhage patients with an apparent ceiling effect.
Conclusions-—The ISAN score is a simple tool for predicting SAP in clinical practice. External validation is required in ischemic and
hemorrhagic stroke cohorts. ( J Am Heart Assoc. 2015;4:e001307 doi: 10.1161/JAHA.114.001307)
Key Words: clinical risk score • pneumonia • stroke, acute • stroke-associated pneumonia
P neumonia frequently complicates stroke and has a majorimpact on outcome. It occurs in approximately 10% of
patients hospitalized with stroke, most frequently during the
ﬁrst week after stroke, and particularly the ﬁrst 3 days after
stroke onset.1 In those at greatest risk, the incidence of
stroke-associated pneumonia (SAP) may be as high as 40%.2
Several studies have highlighted the adverse impact of
infections on the outcome of stroke. SAP independently
increases in-hospital mortality 2- to 6-fold, and increases
hospitalization costs, length of stay, and likelihood of poor
outcome in survivors.3–10 As SAP is a potentially modiﬁable
cause of morbidity and mortality, identifying patients at
greatest risk in the acute phase of stroke is of fundamental
importance in approaching prevention and treatment.
Baseline clinical factors such as dysphagia/aspiration, age,
and stroke severity are consistently associated with SAP, and
several recent studies have developed clinical scores to
predict SAP with the aim of improving risk-stratiﬁcation in
patients with acute ischemic stroke.2,11–14 However, the
utility of such scores in routine clinical care or research
remains unclear. The simplest score, the A2DS2 (Age, Atrial
ﬁbrillation [AF], Dysphagia, Sex, Stroke Severity using the
National Institutes of Health Stroke Scale [NIHSS] score), was
derived in a German cohort,2 and subsequently validated
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using German2 and Chinese registry data.14 Reﬁning predic-
tion scores to make application easier, while improving
reliability and validity in acute stroke patients, is essential
prior to consideration of implementation in research or clinical
practice. We aimed to explore whether a simpler scoring
system could be derived in a cohort of unselected stroke
patients, and compare its performance with that of the A2DS2
score.
Patients and Methods
We undertook secondary analyses of a multicenter UK cohort
study using data collected prospectively in the Sentinel Stroke
National Audit Programme (SSNAP) registry core-dataset.
SSNAP is a UK-wide resource with the objective of improving
the quality of stroke care by auditing stroke services against
evidence-based standards. Ethical approval of the SSNAP
audit and associated data linkage was granted by the Ethics
and Conﬁdentiality Committee of the National Information
Governance Board. SSNAP is administered centrally by the
Royal College of Physicians Stroke Working Party and has
been collecting data since January 2013. Participating hospi-
tals in England, Wales, and Northern Ireland enter data for all
conﬁrmed stroke admissions into a secure online database,
covering a range of prespeciﬁed domains of care (imaging;
stroke unit care; thrombolysis; specialist assessments; occu-
pational therapy; physiotherapy; speech and language ther-
apy; multidisciplinary teamworking; and discharge processes).
Case ascertainment was estimated through linkage with
administrative data. The mortality status of patients was
determined through linkage to the national statutory register
of deaths in England. Data linkage was carried out by a secure
third party (the Health and Social Care Information Centre),
and the investigators were provided with an anonymized
dataset following removal of patient identiﬁers.
Eligibility, Data Collection, and Deﬁnitions
Patients with index ischemic stroke or intracerebral hemor-
rhage (ICH) entered into the SSNAP database between
January 1 and September 31, 2013 with complete data at
baseline through day 7 were eligible for inclusion (69% of
SSNAP database entries). The primary outcome measure was
clinician diagnosis of SAP based on initiation of antibiotic
therapy occurring within the ﬁrst 7 days after admission as
recorded by the participating centers. The following routine
clinical baseline factors were included: age; sex; prestroke
modiﬁed Rankin Scale (score 0 to 5); index stroke subtype
(cerebral infarction or ICH determined by clinician diagnosis
and baseline imaging); presentation stroke severity (NIHSS);
baseline comorbidities: hypertension, diabetes mellitus, con-
gestive heart failure (reported or documented past history
and/or receiving relevant prescribed medication at admis-
sion), AF (reported or documented past history and/or
documentation of standard electrocardiographic ﬁndings at
admission), and previous stroke or transient ischemic attack
(reported or documented past history preceding the index
admission stroke). Dysphagia status was derived from the
baseline swallow screen (within 4 hours of admission) and
formal swallow assessment by a speech and language
therapist (SALT) within 72 hours as follows (Figure 1): no
dysphagia if did not receive a SALT assessment because
baseline swallow screen was passed; dysphagia if received a
SALT assessment or if did not receive a SALT assessment as a
result of organizational reasons, patient refusal, or being
medically unwell. “Organizational reasons” refers to reasons
for not receiving a SALT assessment that are not related to
patient factors—such as lack of availability of appropriately
trained staff or that this was omitted in error as a result of
suboptimal care. Patients were excluded if no reason was
given for not having a SALT assessment. Level of conscious-
ness and other baseline neurological impairments were
retrieved from the complete baseline NIHSS record compris-
ing 11 categories.15 The 10-point A2DS2 score was assigned
as described previously.2
Statistical Analyses
The data were split at random into derivation and validation
samples of patients with ischemic stroke or ICH. Univariate
analyses were undertaken to determine the clinical factors
associated with SAP in the derivation cohort. As dysphagia
status was derived indirectly from swallow screen and SALT
assessment, it was not included in the uni- or multivariable
analyses. Univariable hypothesis tests used were v2 for
categorical variables and Mann–Whitney U test for continuous
variables.
A risk score for SAP was derived by ﬁtting a multivariable
logistic regression model to the derivation data. There were
no missing data in the study sample, and models were ﬁtted
to the complete sample. Initial variables were selected based
on the results of the univariate analyses, clinical experience,
and previously published literature on SAP risk factors.
Variables were selected by a process of backward elimination,
keeping covariables signiﬁcant to P<0.1. Nonsigniﬁcant
covariables were removed sequentially, aiming to derive a
parsimonious model with the highest predictive characteris-
tics. Variable selection took into account the need for the ﬁnal
risk score to be useful in a clinical setting and be simple to
calculate. Model ﬁtting explored various strategies to include
continuous and ordinal variables, either natively, or grouped
into categorical variables. Where nonlinear associations were
identiﬁed, these variables were included as categorical
variables.
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The coefﬁcients from the ﬁnal model were used to derive
an integer-based risk score. The characteristics of the novel
and A2DS2 risk scores were evaluated in the validation sample
using receiving operating characteristic analysis (discrimina-
tion) and by plotting predicted versus observed for each level
of the risk score (calibration). The primary analyses were
restricted to ischemic stroke. Secondary analyses were
undertaken for those with ICH. Sensitivity analyses were
carried out in the ICH group, excluding patients who died
within 3 days of admission, and also after excluding any
patients receiving palliative care. This was to examine the
effect of the competing risk of death of ICH patients or those
patients receiving palliative care estimated to be at high risk
of SAP.
Results
Baseline Characteristics of the Derivation and
Validation Cohorts
Data were available for 23 199 patients with acute stroke
admitted to 218 stroke services. The characteristics of the
patients were well balanced between the derivation and
validation cohorts (Table 1). The median age of the cohort
was 76 years, with ischemic stroke in 92% and ICH in 8%.
Overall prevalence of SAP within the ﬁrst week of admission
was 6.7%, with a prevalence of 6.5% in the patients with
ischemic stroke and 8.5% in patients with ICH. Both 7-day and
30-day all-cause mortality rates were similar between the
derivation and validation cohorts. Patients excluded because
of incomplete data at baseline (incomplete NIHSS) tended to
be older, more dependent prestroke, with more frequent ICH
and higher mortality (Table 2).
Predictors of SAP and Derivation of the ISAN
Clinical Risk Score
Baseline factors associated with SAP in the uni- and
multivariable analyses are presented in Tables 3 and 4. The
integer-based pneumonia risk score (ISAN ) derived from the
validation cohort ranged from 0 to 21 (Table 5), and consists
of 4 variables available on admission: prestroke Independence
(modiﬁed Rankin Scale 0 to 1 versus 2 to 5); Sex; Age (5
categories); NIHSS (4 categories). The greatest weightings
were for older age and higher stroke severity on the NIHSS.
Discrimination of the ISAN Score and Comparison
With the A2DS2 Score
The discrimination of the ISAN score was good in both the
derivation and validation cohorts of ischemic stroke patients,
with a C-statistic of 0.78 (95% CI 0.76 to 0.80) in the
validation cohort (Table 6). The C-statistic for the A2DS2 score
was very similar (0.79, 0.77 to 0.81). Discrimination of the
ISAN score was less good in patients with ICH, with a C-
statistic of 0.71 (0.66 to 0.77), while the C-statistic for the
Formal swallow 
assessment by SALT 
n=7,525 
 
Final cohort 
n=23,199 
No formal swallow 
assessment by SALT 
n=15,674 
 
Organisaonal 
reasons 
n=995 
 
Paent refused 
n=41 
Paent medically 
unwell 
n=1,473 
 
Paent passed 
swallow screen 
n=12,333 
 
Not known 
n=832 
 
Suspected dysphagia 
Figure 1. Flow chart deﬁning allocation of dysphagia status. SALT indicates speech and language
therapist.
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A2DS2 score was 0.72 (0.67 to 0.77). Both scores also
performed similarly in the subgroup of ICH patients who
survived the ﬁrst 3 days of admission. In the validation
sample, 5.2% of those patients received palliative care.
Excluding these patients had a similar effect on discrimination
in the ICH patients (Table 6).
Calibration of the ISAN Score
In the validation cohort, the ISAN score was well calibrated
across each of the 22 levels in ischemic stroke patients
(Figure 2A). The prevalence of SAP was 1.3% for patients with
a score of 0, rising to >30% in patients with an ISAN score of
>18. The calibration plot for patients with ICH (Figure 2B)
shows evidence of a ceiling effect, with scores above 15
tending to overestimate the risk of SAP in these patients.
ISAN Score Risk Categories
Aggregation of the ISAN score showed that 4 risk groupings
meaningfully identiﬁed populations at high or low risk of SAP
(Table 7). The low (score 0 to 5) and medium (score 6 to 10)
risk groups together accounted for 77% of the validation
sample, and the prevalence of SAP in these groups was 1.6%
and 4.9%, respectively. 15.5% of the patients were in the high
(score 11 to 14) risk category, and had a 12.6% (ischemic
stroke) or 15.7% (ICH) prevalence of SAP. The group at
highest predicted risk (score 15+) accounted for 8.3% of the
Table 1. Characteristics of the Derivation and Validation Cohorts
Derivation Validation P Value
N 11 551 11 648
Female (%) 5425 (47.0) 5594 (48.0) 0.003
Median age (IQR) 76 (65 to 84) 76 (65 to 84) 0.46
Age group, n (%) (y) 0.881
<60 1909 (16.5) 1884 (16.2)
60 to 69 2029 (17.6) 2044 (17.6)
70 to 79 3167 (27.4) 3167 (27.2)
80 to 89 3355 (29.1) 3442 (29.6)
90+ 1091 (9.5) 1110 (9.5)
Stroke type, n (%) 0.39
Ischemic 10 635 (92.1) 10 699 (91.9)
ICH 916 (7.9) 949 (8.2)
Median NIHSS (IQR) 4 (2 to 9) 4 (2 to 9) 0.34
Dependent prestroke, n (%) 2761 (23.9) 2793 (24.0) 0.8
Comorbidity, n (%)
Congestive heart failure 609 (5.3) 630 (5.4) 0.09
Atrial fibrillation 2213 (19.2) 2186 (18.8) 0.53
Hypertension 6228 (53.9) 6389 (54.9) 0.88
Diabetes mellitus 2271 (19.7) 2224 (19.1) 0.27
Previous stroke or TIA 3072 (26.6) 3073 (26.4) 0.62
Dysphagia, n (%) 4976 (44.7) 5058 (45.0) 0.69
Pneumonia, n (%) 772 (6.7) 751 (6.7) 0.78
7-day mortality, n (%) 407 (3.5) 403 (3.5) 0.27
7-day mortality—ischemic stroke, n (%) 307 (2.9) 292 (2.7) 0.85
7-day mortality—ICH, n (%) 100 (10.9) 111 (11.7) 0.77
30-day mortality, n (%) 853 (7.4) 839 (7.2) 0.04
30-day mortality—ischemic stroke, n (%) 707 (6.7) 671 (6.3) 0.63
30-day mortality—ICH, n (%) 146 (15.9) 168 (17.7) 0.51
ICH indicates intracerebral hemorrhage; IQR, interquartile range; NIHSS, National Institutes of Health Stroke Scale; TIA, transient ischemic attack.
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stroke population and had a prevalence of SAP of 26.4%
(ischemic stroke) and 21.9% (ICH). The relative risk of SAP in
ischemic stroke was 7.9 (95% CI 6.0 to 10.5) and 16.5 (95%
CI 12.6 to 21.9) in the high and very high categories,
respectively, compared to patients in the low-risk category.
Similarly, comparing to the low-risk group in ICH, the relative
risk of SAP was 5.6 (95% CI 2.6 to 12.4) and 7.8 (95% CI 3.6
to 17.2) in the high and very high categories, respectively.
Discussion
Despite improvements in acute stroke care, the impact of SAP
on mortality may have changed little in recent years.9
Prediction of patients at greatest risk of SAP could be of
major importance in individualized monitoring and prognos-
tication, and stratifying inclusion in clinical trials of preven-
tative therapies (eg, antibiotics). We undertook a model
development study with the aim of deriving and internally
validating a novel clinical risk score for predicting SAP in a
large national cohort of contemporary stroke patients. The
ISAN score exhibited good discrimination and was well
calibrated in ischemic stroke, and identiﬁed a clinically
meaningful spectrum of SAP risk when aggregated into 4
scoring categories.
An important consideration is how the ISAN score
performs in comparison to existing SAP prediction scores
developed for ischemic stroke (Table 8). In terms of discrim-
ination, the ISAN score performed comparably to the A2DS2
score in our validation sample and at least as well as the
A2DS2 and AIS-APS scores in the previous studies.2,14 We
were unable to externally validate the AIS-APS in our cohort
as several components of the score (ie, current smoking
status, chronic obstructive pulmonary disease, Glasgow Coma
Scale score, blood glucose) are not recorded in the SSNAP
dataset.
A second consideration is the potential usefulness of
prediction scores in clinical practice and research. As SAP
develops most frequently in the ﬁrst days after stroke,
preventative strategies need to be administered as soon as
possible after stroke onset. To facilitate such early risk-
stratiﬁcation of patients at greatest risk, prediction scores
should be simple, based on valid, reliable, readily available
clinical parameters, and quick to apply. The ISAN score is
simple, incorporating only 4 clinical factors that are available
at emergency presentation. By contrast, deﬁnitive past
Table 2. Characteristics of the SSNAP Patients Excluded and
Included
Excluded (NIHSS
Incomplete) Included (NIHSS Complete)
N 10 229 23 199
Median age (IQR) 80 (69 to 86) 76 (65 to 84)
Female (%) 5639 (54) 11 260 (48)
Stroke type, n (%)
Ischemic 8756 (86) 21 334 (92)
ICH 1473 (14) 1865 (8)
Dependent prestroke (%) 3504 (34) 5639 (24)
Comorbidity, n (%)
CCF 660 (6.3) 1250 (5.3)
Atrial fibrillation 2357 (23) 4452 (19)
Hypertension 5301 (51) 12 788 (54)
Diabetes mellitus 1960 (19) 4553 (19)
Previous stroke or TIA 3096 (30) 6234 (27)
7-day mortality, n (%) 1108 (10.6) 820 (3.5)
30-day mortality, n (%) 2034 (19.5) 1708 (7.3)
CCF indicates congestive cardiac failure; ICH, intracerebral hemorrhage; IQR,
interquartile range; NIHSS, National Institutes of Health Stroke Scale; SSNAP, Sentinel
Stroke National Audit Programme; TIA, transient ischemic attack.
Table 3. Univariable Predictors of Pneumonia in the
Derivation Cohort
Item OR 95% CI
Male 1.23 1.10 to 1.37
Age group, y
<60 Ref
60 to 69 1.50 1.11 to 2.02
70 to 79 2.64 2.04 to 3.43
80 to 89 4.29 3.34 to 5.50
90+ 6.46 4.95 to 8.42
Stroke subtype
Ischemic Ref
ICH 1.44 1.22 to 1.70
Comorbidities
CCF 2.07 1.72 to 2.49
Hypertension 1.02 0.91 to 1.14
Atrial fibrillation 1.9 1.69 to 2.15
Diabetes mellitus 0.97 0.85 to 1.12
Stroke/TIA 1.23 1.09 to 1.38
Dependent prestroke 2.80 2.51 to 3.13
NIHSS on admission
0 to 4 Ref
5 to 15 3.38 2.77 to 4.13
6 to 20 9.58 7.50 to 12.2
21+ 13.2 10.5 to 16.7
CCF indicates congestive cardiac failure; ICH, intracerebral hemorrhage; NIHSS, National
Institutes of Health Stroke Scale; TIA, transient ischemic attack.
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medical history (eg, AF, chronic obstructive pulmonary
disease, congestive heart failure) may not always be available
without some delay. Detection of AF in the acute phase of
stroke is inﬂuenced by the frequency of electrocardiography
and duration of inpatient telemetry.16 Dysphagia screening
techniques and the incidence of dysphagia reported in acute
stroke are also variable.17–19 Since the availability of past
medical history and recognition of AF and dysphagia may vary
between different units, the ISAN score may be both simpler
to apply and less prone to interobserver variation than other
scores. The 4 risk-categories of the ISAN score potentially
increase its usefulness in both clinical trial and routine care
settings.
To the best of our knowledge, this is the ﬁrst study to apply
SAP prediction scores to patients with ICH. While rates of
pneumonia are reportedly higher in patients with ICH than
ischemic stroke,20,21 early neurological deterioration and
death resulting from intracranial sequelae of the initial
hematoma occur frequently.22–24 This may lead to under-
reporting of SAP in ICH either because early neurological
Table 4. Multivariable Predictors of Pneumonia in the
Derivation Cohort
Item aOR 95% CI
Age group, y
<60 Ref
60 to 69 2.24 1.41 to 3.55
70 to 79 3.11 2.03 to 4.76
80 to 89 4.72 3.12 to 7.16
90+ 5.96 3.82 to 9.28
Sex
Female Ref
Male 1.23 1.04 to 1.46
NIHSS on admission
0 to 4 Ref
5 to 15 2.87 2.33 to 3.54
16 to 20 6.47 4.93 to 8.48
21+ 9.38 7.31 to 12.05
mRS prestroke
Independent Ref
Not independent 1.62 1.36 to 1.93
aOR indicates adjusted odds ratio; mRS, modiﬁed Rankin scale; NIHSS, National
Institutes of Health Stroke Scale.
Table 5. ISAN Score Components and Weightings
Item Score
Age, y
<60 0
60 to 69 3
70 to 79 4
80 to 89 6
90+ 8
Sex
Female 0
Male 1
NIHSS on admission
0 to 4 0
5 to 15 4
16 to 20 8
21+ 10
mRS prestroke
Independent 0
Not independent 2
ISAN indicates prestroke Independence (modiﬁed Rankin scale), Sex, Age, National
Institutes of Health Stroke Scale; mRS, modiﬁed Rankin scale; NIHSS, National Institutes
of Health Stroke Scale.
Table 6. C-Statistics (95% CI) for the ISAN and A2DS2 Scores
in the Derivation and Validation Samples and Sensitivity
Analyses
Derivation Validation P Value
Ischemic stroke
ISAN 0.79 (0.77
to 0.81)
0.78 (0.76 to 0.80) 0.008
A2DS2 — 0.79 (0.77 to 0.81)
Ischemic
stroke (excluding
palliative care)
ISAN — 0.78 (0.76 to 0.80) 0.01
A2DS2 — 0.79 (0.77 to 0.81)
ICH
ISAN — 0.71 (0.66 to 0.77) 0.32
A2DS2 — 0.72 (0.67 to 0.77)
ICH (excluding
patients dying
within 3 days)
ISAN — 0.75 (0.69 to 0.80) 0.20
A2DS2 — 0.76 (0.71 to 0.81)
ICH (excluding
palliative care)
ISAN — 0.76 (0.71 to 0.82) 0.30
A2DS2 — 0.77 (0.72 to 0.83)
A2DS2 indicates age, atrial ﬁbrillation, dysphagia, sex, stroke severity (National Institutes
of Health Stroke Scale); ICH, intracerebral hemorrhage; ISAN, prestroke Independence
(modiﬁed Rankin scale), Sex, Age, National Institutes of Health Stroke Scale.
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deterioration confounds clinical diagnosis of evolving SAP, or
by decisions not to treat SAP based on perceived futility. The
ISAN and A2DS2 scores performed similarly for patients with
ICH but less well than for ischemic stroke. There was
evidence of a ceiling effect at the higher end of the ISAN
scoring range, which is most likely attributable to the
competing risk of early death in ICH.
Strengths of our study include model development within
a large, multicenter national registry representative of real-
world UK stroke care, with prospectively collected data.
However, our study also has limitations. First, nearly one
third of SSNAP database patient entries were excluded from
the analyses due to incomplete baseline data. This may have
underestimated prevalence of pneumonia, particularly as the
excluded patients tended to be older, with ICH, and had
higher mortality. Second, other baseline factors not recorded
in the SSNAP registry, for example, medications (eg, statins,
proton-pump inhibitors, or angiotensin-converting enzyme
inhibitors), baseline vital signs, or intubation/ventilation may
inﬂuence pneumonia risk. Third, as dysphagia status was
derived indirectly, it was not incorporated into the model-
building. Patients who refused a SALT assessment, were too
unwell, or did not receive an assessment due to organiza-
tional reasons were allocated dysphagic status by default,
which may have overestimated the frequency of dysphagia.
However, as the dysphagia rates in the German and Chinese
cohorts varied between 8% and 24% (Table 8), it is unlikely
that this alone accounted for the higher frequency of
dysphagia in our study. As the NIHSS score is correlated
with dysphagia and age,25,26 exclusion of dysphagia from the
ISAN score is unlikely to have adversely inﬂuenced face
validity. Indeed, admission NIHSS exhibited better test
characteristics for predicting dysphagia than a dysphagia
screening tool in 1 study.27 Fourth, while the modiﬁed
Rankin Scale is widely used in research and clinical practice,
the interobserver reliability of assigning prestroke modiﬁed
Rankin Scale is moderate, and may lack validity in rating
prior independence.28 Finally, our deﬁnition of SAP was
based on individual clinician-based diagnosis. Diagnosis of
SAP is challenging as presentation may be nonspeciﬁc,
cough is impaired, fever occurs frequently without infection,
microbiological samples have limited practical value, and
chest radiography, a central component of diagnostic
criteria, may have limited utility in the early stages.29 Use
A
B
Figure 2. Calibration plots of the ISAN score in patients with (A)
ischemic stroke and (B) intracerebral hemorrhage. Vertical lines are
95% CIs. ISAN indicates prestroke Independence (modiﬁed Rankin
scale), Sex, Age, National Institutes of Health Stroke Scale.
Table 7. Prevalence of Pneumonia and Mortality by ISAN Risk Group in the Validation Cohort
Risk
Category Score
% of
Cohort
7-Day
Mortality (%)
30-Day
Mortality (%)
Ischemic Stroke (N=10 699) ICH (n=949)
SAP Prevalence (%, 95% CI) Relative Rate (95% CI)
SAP Prevalence
(%, 95% CI)
Relative
Rate (95% CI)
Low 0 to 5 38.5 0.3 0.8 1.6 (1.2 to 5.5) 1 2.8 (1.2 to 5.5) 1
Medium 6 to 10 37.8 1.6 4.2 4.9 (4.2 to 5.6) 3.1 (2.3 to 4.1) 7.4 (4.8 to 10.8) 2.6 (1.2 to 5.9)
High 11 to 14 15.5 6.3 13.4 12.6 (11.0 to 14.5) 7.9 (6.0 to 10.5) 15.7 (10.3 to 22.8) 5.6 (2.6 to 12.4)
Very high 15+ 8.3 21.4 40.0 26.4 (22.9 to 30.1) 16.5 (12.6 to 21.9) 21.9 (14.8 to 21.3) 7.8 (3.6 to 17.2)
ICH indicates intracerebral hemorrhage; ISAN, prestroke Independence (modiﬁed Rankin scale), Sex, Age, National Institutes of Health Stroke Scale; SAP, stroke-associated pneumonia.
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of standardized diagnostic criteria with independent adjudi-
cation might provide a more rigorous approach to diagnosing
SAP, but there are currently no universally agreed or
validated diagnostic criteria for SAP. Interestingly, the
prevalence of SAP was similar in the SSNAP and German
cohorts where clinician-based diagnosis was used, but higher
in the Chinese Registry where the Centers for Disease
Control and Prevention criteria were prospectively applied
(Table 8). These variations could relate to underlying popu-
lation differences, but may also reﬂect different thresholds
for initiation of antibiotics when pneumonia is clinically
suspected, or underdiagnosis in the absence of a standard-
ized diagnostic approach.
In conclusion, the ISAN score, which is simple to use and
performed similarly to previously described scores, is a
promising tool for predicting SAP in acute stroke care. The
ISAN score requires external validation and reﬁnement,
preferably in large prospective multicenter studies with
adjudicated and standardized deﬁnition of SAP, plus evalua-
tion of clinician behaviors in using the score, relative to usual
practice or clinical judgment.
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Table 8. Comparison of Cohort Characteristics and Discrimination of ISAN, A2DS2, and AIS-APS Scores
Cohort
SSNAP Berlin NWSR CNSR CICAS
Derivation
Internal
Validation Derivation
External
Validation Derivation Validation External Validation
N 11 551 11 648 15 335 45 085 8820 5882 3037
Rate of
pneumonia (%)
6.7 6.7 7.2 7.8 11.4 11.3 7.3
Diagnosis of
pneumonia
Clinician-reported diagnosis Clinician-reported diagnosis CDC criteria CDC criteria
ICH (%) 916 (8) 948 (8)
Median age (y, IQR) 76 (65 to 84) 76 (65 to 84) 72 (64 to 81) 74 (65 to 81) 66 (56 to 74) 66 (57 to 75) 64 (54 to 72)
Male sex (%) 6126 (53) 6054 (52) 7759 (51) 22 801 (51) 5430 (62) 3675 (63) 1997 (66)
Median NIHSS
score (IQR)
4 (2 to 9) 4 (2 to 9) 4 (2 to 10) 5 (2 to 10) 5 (2 to 9) 5 (2 to 9) 4 (2 to 7)
Dysphagia (%) 4976 (45) 5058 (45) 3507 (23) 10 465 (24) 840 (10) 529 (9) 236 (8)
Prestroke
dependent (%)
2761 (24) 2793 (24) 2866 (21) 6754 (19) 809 (9) 535 (9) 0 (0)
Previous stroke (%) 3072 (27) 3073 (26) 4320 (28) 11 800 (27) 2795 (32) 1822 (31) 777 (26)
Atrial fibrillation (%) 2213 (19) 2186 (19) 4139 (27) 12 337 (28) 643 (7) 415 (7) 180 (6)
Diabetes mellitus (%) 2271 (20) 2224 (19) 4783 (31) 13 146 (30) 1834 (21) 1287 (22) 742 (24)
Hypertension (%) 6228 (54) 6389 (55) 11 358 (86) 30 978 (87) 5601 (64) 3683 (63) 2016 (66)
ISAN (C-statistic; 95% CI) 0.79 (0.77
to 0.81)
0.78 (0.76
to 0.80)
A2DS2 (C-statistic; 95% CI) 0.79 (0.77
to 0.81)
0.84 (0.83
to 0.85)
0.84 (0.83
to 0.84)
0.75 (0.74
to 0.75)
0.73 (0.72
to 0.74)
0.76 (0.74
to 0.77)
AIS-APS (C-statistic;
95% CI)
0.80 (0.78
to 0.81)
0.79 (0.77
to 0.80)
0.79 (0.76
to 0.82)
A2DS2 indicates age, atrial ﬁbrillation, dysphagia, sex, stroke severity (National Institutes of Health Stroke Scale); AIS-APS, acute ischemic stroke–associated pneumonia score; CDC,
Centers for Disease Control and Prevention; CICAS, Chinese Intracranial Atherosclerosis Study; CNSR, Chinese National Stroke Registry; ICH, intracerebral hemorrhage; IQR, interquartile
range; ISAN, prestroke Independence (modiﬁed Rankin scale), Sex, Age, National Institutes of Health Stroke Scale; NIHSS, National Institutes of Health Stroke Scale; NWSR, North-West
Germany Stroke Register; SSNAP, Sentinel Stroke National Audit Programme.
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